Connect your AI

Evolent Health, Inc. EVH Restricted Cash

Restricted Cash at other companies

Alignment HealthcareALHC

$2.13M+1.7%

ExlService HoldingsEXLS

$12.41M+26.3%

Community Financial SystemCBU

$14.76M+189%

Claritev CorporationCTEV

$13.4M+24.4%

CVS HealthCVS

——

Other financials

Income statement

Revenue$496.2M+2.6%

Gross profit$83.8M-18.2%

Operating income-$10.6M-553%

Net income-$26.6M+58.8%

EPS (diluted)-$0.24+61.9%

Balance sheet

Cash & equivalents$142.0M-42.4%

Total debt$985.4M+13.3%

Total equity$396.4M-57.6%

Total assets$1.9B-29.2%

Cash flow

Operating cash flow-$984.0K-122%

Valuation

Market cap$565.78M-47.9%

Enterprise value$1.41B-17.6%

P/S0.3×-0.2×

Profitability

Gross margin20.2%+4.9pp

Operating margin-22.2%-23.5pp

Net margin-26.3%-33.2pp

FCF margin-9.7%—

Returns & leverage

Return on equity-74.6%-90.1pp

Debt / equity2.5×+1.6×

Current ratio1.3×+0.3×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndInvestmentsCurrent.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evolent Health, Inc.'s restricted cash?: Evolent Health, Inc. (EVH) reported restricted cash of $23.98M in Q1 2026.
How has Evolent Health, Inc.'s restricted cash changed year-over-year?: Evolent Health, Inc.'s restricted cash increased by 47.7% year-over-year, from $16.24M to $23.98M.
What is the long-term trend for Evolent Health, Inc.'s restricted cash?: Over 5 years (2020 to 2025), Evolent Health, Inc.'s restricted cash has grown at a 12.7% compound annual growth rate (CAGR), from $14.37M to $26.13M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.